When treated with Hem07 WT1-CTLs (E:T 0.5), 45.6% of OCI-AML2 cells were alive at 24 h; co-treatment with VEN 100 nM dropped AML cell viability to an average of 6.9%. This evidence concerns the gene WT1 and acute myeloid leukemia.